Enriched QUARTET® Hen Eggs and Cardiovascular Function

NCT ID: NCT04564690

Last Updated: 2020-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-01

Study Completion Date

2022-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Role of oxidative stress in the development of cardiovascular diseases is well known and extensively investigated, because of its direct effects on vascular function, but also on the activation of the immune response. Thus, food products that could increase the antioxidant capacity of the vascular system would also act protective against cardiovascular diseases. However, we lack systematic clinical and pre-clinical research with food products instead of food supplements, which would result in consistent and repeatable results. Many studies have proven the effectiveness of n-3 polyunsaturated fatty acids (n-3 PUFA) in improvement of endothelial function, improvement of elasticity of the vascular wall and the anti-inflammatory effects in patients with chronic diseases, such as metabolic syndrome, if they are taken as an pharmacological preparation. Our research group recently reported that favorable anti-inflammatory properties of n-3 PUFA enriched hen eggs potentially contribute to the improvement of microvascular endothelium-dependent vasodilation in healthy individuals. In addition, this study aimed to determine the effect of QUARTET® hen eggs (enriched in n-3 PUFA, selenium, vitamin E and lutein; QUARTET No. 012743696, 2014.) consumption on cardiovascular function in both healthy individuals and cardiovascular patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

n-3 Polyunsaturated Fatty Acids Selenium Vitamin E Lutein

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

QUARTET®

Consumption of three QUARTET® (n-3 PUFA, selenium, vitamin E, lutein enriched) hen eggs per day for three weeks

Group Type EXPERIMENTAL

QUARTET® hen eggs (enriched in n-3 PUFA, selenium, vitamin E and lutein)

Intervention Type DIETARY_SUPPLEMENT

Consumption of three QUARTET® hen eggs (enriched in n-3 PUFA, selenium, vitamin E and lutein) per day for three weeks

Control

Consumption of three regular hen eggs per day for three weeks

Group Type EXPERIMENTAL

Regular hen eggs

Intervention Type DIETARY_SUPPLEMENT

Consumption of three regular hen eggs per day for three weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

QUARTET® hen eggs (enriched in n-3 PUFA, selenium, vitamin E and lutein)

Consumption of three QUARTET® hen eggs (enriched in n-3 PUFA, selenium, vitamin E and lutein) per day for three weeks

Intervention Type DIETARY_SUPPLEMENT

Regular hen eggs

Consumption of three regular hen eggs per day for three weeks

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy volunteers (sedentary)
* healthy volunteers (athletes)
* cardiac patients (patients with acute myocardial infarction, hypertensive patients with/without hypertensive heart disease, heart failure patients)

Exclusion Criteria

* oral contraceptives
* drugs that could affect endothelium
* hypertension
* coronary artery disease
* diabetes
* hyperlipidaemia
* renal impairment
* cerebrovascular and peripheral artery disease


* known malignant disease
* hereditary metabolic diseases and other hereditary systemic diseases
* autoimmune diseases or systemic diseases with immunopathology
* unregulated hypertension
* recent surgery (3 months)
* recent significant trauma (6 months)
* renal insufficiency (except in diabetic patients unless Endogenous Creatinine Clearance \> 60ml / min)
* active bleeding (hematuria, GI tract, menorrhagia)
* fresh ICV (6 weeks)
* neurodegenerative diseases and epilepsy
* significant anemia (Hg \<110 (men), \<100 (women))
* condition after resuscitation (3 months)
* therapy that significantly affects vascular or immune function (monoclonal antibodies, immunosuppressants, systemic corticosteroids ...)
* chronic respiratory failure and conditions of chronic hypoxemia
* sepsis and chronic active infections with systemic inflammatory response (active tuberculosis, etc.)
* untreated thyroid disease
* active abuse of alcohol and drugs
* liver failure (advanced liver disease with impaired synthetic and metabolic function)
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Josip Juraj Strossmayer University of Osijek

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ines Drenjancevic

Head of Scientific center of excellence for personalized health care

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Scientific Center of Excellence for Personalized Health Care, Josip Juraj Strossayer University of Osijek

Osijek, , Croatia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Croatia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ines Drenjancevic, MD, PhD

Role: CONTACT

+385912241406

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ines Drenjancevic, MD, PhD

Role: primary

+385912241406

References

Explore related publications, articles, or registry entries linked to this study.

Stupin A, Rasic L, Matic A, Stupin M, Kralik Z, Kralik G, Grcevic M, Drenjancevic I. Omega-3 polyunsaturated fatty acids-enriched hen eggs consumption enhances microvascular reactivity in young healthy individuals. Appl Physiol Nutr Metab. 2018 Oct;43(10):988-995. doi: 10.1139/apnm-2017-0735. Epub 2018 Apr 10.

Reference Type BACKGROUND
PMID: 29633621 (View on PubMed)

Stupin M, Kibel A, Stupin A, Selthofer-Relatic K, Matic A, Mihalj M, Mihaljevic Z, Jukic I, Drenjancevic I. The Physiological Effect of n-3 Polyunsaturated Fatty Acids (n-3 PUFAs) Intake and Exercise on Hemorheology, Microvascular Function, and Physical Performance in Health and Cardiovascular Diseases; Is There an Interaction of Exercise and Dietary n-3 PUFA Intake? Front Physiol. 2019 Aug 30;10:1129. doi: 10.3389/fphys.2019.01129. eCollection 2019.

Reference Type BACKGROUND
PMID: 31543828 (View on PubMed)

Stupin A, Mihalj M, Kolobaric N, Susnjara P, Kolar L, Mihaljevic Z, Matic A, Stupin M, Jukic I, Kralik Z, Grcevic M, Kralik G, Seric V, Drenjancevic I. Anti-Inflammatory Potential of n-3 Polyunsaturated Fatty Acids Enriched Hen Eggs Consumption in Improving Microvascular Endothelial Function of Healthy Individuals-Clinical Trial. Int J Mol Sci. 2020 Jun 10;21(11):4149. doi: 10.3390/ijms21114149.

Reference Type BACKGROUND
PMID: 32532035 (View on PubMed)

Susnjara P, Kolobaric N, Matic A, Mihaljevic Z, Stupin A, Marczi S, Drenjancevic I. Consumption of Hen Eggs Enriched with n-3 Polyunsaturated Fatty Acids, Selenium, Vitamin E and Lutein Incites Anti-Inflammatory Conditions in Young, Healthy Participants - A Randomized Study. Front Biosci (Landmark Ed). 2022 Dec 27;27(12):332. doi: 10.31083/j.fbl2712332.

Reference Type DERIVED
PMID: 36624951 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

#KK.01.1.1.01.0010

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Diet and Vascular Health Study
NCT01114399 COMPLETED NA
Palmitic Acid and Human Microvascular Function
NCT06683534 NOT_YET_RECRUITING PHASE2
Quercetin in Coronary Artery By-pass Surgery
NCT04907253 ACTIVE_NOT_RECRUITING PHASE2
Cardiovascular and InflammAging Study
NCT04763291 ACTIVE_NOT_RECRUITING NA